The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(2,4-dichlorophenyl)-5-propylthiazol-2-yl)-4-methyl-1,2,3-thiadiazole-5-carboxamide ID: ALA2252692
PubChem CID: 44128016
Max Phase: Preclinical
Molecular Formula: C16H14Cl2N4OS2
Molecular Weight: 413.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCc1sc(NC(=O)c2snnc2C)nc1-c1ccc(Cl)cc1Cl
Standard InChI: InChI=1S/C16H14Cl2N4OS2/c1-3-4-12-13(10-6-5-9(17)7-11(10)18)19-16(24-12)20-15(23)14-8(2)21-22-25-14/h5-7H,3-4H2,1-2H3,(H,19,20,23)
Standard InChI Key: VYMWSTJWKXWWNV-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
30.1288 -12.5963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8365 -12.1877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.4211 -12.1877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1288 -13.4135 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.3309 -11.3734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5316 -11.2035 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.1229 -11.9112 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6698 -12.5184 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.5442 -12.5963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6341 -13.4087 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.4335 -13.5786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8421 -12.8709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2952 -12.2637 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9367 -10.8249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6505 -12.7843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1305 -13.4471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9425 -13.3620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2756 -12.6148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7906 -11.9518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9803 -12.0402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7659 -14.3252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2855 -14.9863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6179 -15.7328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4981 -11.3805 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
36.0882 -12.5282 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
1 4 2 0
3 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 3 1 0
2 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 2 0
5 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
12 15 1 0
11 21 1 0
21 22 1 0
22 23 1 0
20 24 1 0
18 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 413.36Molecular Weight (Monoisotopic): 411.9986AlogP: 5.48#Rotatable Bonds: 5Polar Surface Area: 67.77Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.62CX Basic pKa: ┄CX LogP: 6.04CX LogD: 6.03Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.60Np Likeness Score: -2.44
References 1. Fan Z, Shi Z, Zhang H, Liu X, Bao L, Ma L, Zuo X, Zheng Q, Mi N.. (2009) Synthesis and biological activity evaluation of 1,2,3-thiadiazole derivatives as potential elicitors with highly systemic acquired resistance., 57 (10): [PMID:21314199 ] [10.1021/jf8031364 ]